Home › Trial NCT06159166
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
- Trial IDNCT06159166
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorJohns Hopkins University
- Enrollment24
- Start date2024-02-12
- ConditionsNF1 · Cutaneous Neurofibroma · Monotherapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.